Danaher Corporation (DHR) Shares Bought by RMB Capital Management LLC
RMB Capital Management LLC increased its position in Danaher Corporation (NYSE:DHR) by 14.3% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 239,064 shares of the conglomerate’s stock after buying an additional 29,991 shares during the period. Danaher Corporation accounts for about 0.8% of RMB Capital Management LLC’s holdings, making the stock its 17th largest position. RMB Capital Management LLC’s holdings in Danaher Corporation were worth $20,447,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Danaher Corporation by 3.9% in the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock worth $3,503,962,000 after buying an additional 1,530,015 shares during the last quarter. FMR LLC boosted its position in shares of Danaher Corporation by 0.3% in the first quarter. FMR LLC now owns 19,441,167 shares of the conglomerate’s stock worth $1,662,803,000 after buying an additional 53,429 shares during the last quarter. Parnassus Investments CA boosted its position in shares of Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock worth $712,738,000 after buying an additional 1,143,284 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Danaher Corporation by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 7,645,818 shares of the conglomerate’s stock worth $653,946,000 after buying an additional 50,673 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Danaher Corporation by 6.0% in the first quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock worth $496,687,000 after buying an additional 329,458 shares during the last quarter. 76.56% of the stock is currently owned by institutional investors.
Shares of Danaher Corporation (NYSE DHR) traded down 0.39% during midday trading on Tuesday, hitting $81.11. 309,839 shares of the company’s stock traded hands. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01. The company has a 50 day moving average of $83.93 and a 200 day moving average of $84.29. The stock has a market cap of $56.35 billion, a P/E ratio of 25.89 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period last year, the company earned $0.90 earnings per share. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities analysts forecast that Danaher Corporation will post $3.95 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Danaher Corporation (DHR) Shares Bought by RMB Capital Management LLC” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.dailypolitical.com/2017/08/08/danaher-corporation-dhr-shares-bought-by-rmb-capital-management-llc.html.
A number of equities analysts have recently commented on the stock. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a report on Friday. BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Credit Suisse Group reaffirmed a “buy” rating and issued a $93.00 target price on shares of Danaher Corporation in a report on Wednesday, May 24th. Finally, Janney Montgomery Scott cut shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher Corporation presently has a consensus rating of “Buy” and a consensus price target of $91.76.
In other news, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the transaction, the senior vice president now directly owns 39,020 shares in the company, valued at $3,283,923.20. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock worth $3,206,426 over the last ninety days. 12.20% of the stock is owned by corporate insiders.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.